Cover Image
市場調查報告書

全球家畜醫療市場:各產品,診斷技術,動物,地區 - 趨勢及預測

Farm Animal Healthcare Market by Products (vaccines, paraciticides, anti-infectives, medicinal feed additives, and other pharmaceuticals), By diagnostic technologies, by Animal Typ

出版商 Mordor Intelligence LLP 商品編碼 319395
出版日期 內容資訊 英文 190 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球家畜醫療市場:各產品,診斷技術,動物,地區 - 趨勢及預測 Farm Animal Healthcare Market by Products (vaccines, paraciticides, anti-infectives, medicinal feed additives, and other pharmaceuticals), By diagnostic technologies, by Animal Typ
出版日期: 2016年08月01日 內容資訊: 英文 190 Pages
簡介

全球家畜醫療市場預測在2014年將為134億6,000萬美元。一般認為該市場今後將以年複合成長率8.25%的速度持續成長,到2018年達到202億美元的規模。

本報告提供全球家畜醫療市場現況與未來預測,提供您各市場區隔,各地區趨勢,並彙整主要的參與企業競爭環境與簡介等資料。

第1章 簡介

第2章 市場分析

  • 動物醫療產品
  • 動物醫療和人的醫療

第3章 市場趨勢

  • 推動市場的要素
    • 寵物飼主感情
    • 營養的改善
    • 消費者對食品安全性的注意力提升
    • 飼料的增產
    • 動物平原性傳染病及透過食物傳染的疾病
  • 阻礙市場的要素
    • 耕地和水的危機
    • 耕地的競爭激烈
    • 成本效益高的生產
  • 波特五力分析

第4章 市場區隔

  • 各產品
    • 寄生蟲驅除劑
    • 抗發炎藥
    • 醫療用食品添加物
    • 其他的醫藥品
    • 疫苗
  • 家畜
    • 綿羊

第5章 全球家畜診斷藥市場

  • 酵素免疫吸附法
  • 即時免疫移動
  • 寒天凝膠免疫核酸法

第6章 全球家畜遺傳學市場

第7章 各地區市場市場區隔

  • 北美
  • 歐洲
  • 亞太地區

第8章 競爭環境

  • 市場上主要企業
  • 合併·收購
  • 新產品上市
  • 協定,聯合,夥伴關係

第9章 企業簡介

  • Zoetis animal healthcare
  • Merck
  • Merial
  • Elanco
  • Bayer healthcare
  • Novartis Animal Health, Inc.
  • Virbac
  • Boehringer Ingelheim

第10章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Cattle producers have long recognized the need for proper husbandry and stewardship, given the intensive animal husbandry model that currently houses a majority of cattle reared each year. Growing beef production and increasing demand for animal protein in an era of ever stricter regulations for rearing and food safety testing will have a positive impact on the cattle healthcare market. Health consciousness is an increasing concern and as Americans attempt to eat healthier food, producers respond and new products are appearing in the marketplace - and beef is no exception.

Statistics shows that in 2013, global cattle population was estimated to be 1485.2 million and with increasing awareness for cattle healthcare, number is expected to increase further which in turn will propel cattle healthcare market to grow.

In a country wise analysis it is seen that emerging markets such as Eastern Europe, Latin America and Asia are witnessing an increase in share because of the increasing importance given to animal health by the livestock breeders. As these regions are showing very strong economic growth in recent past years, livestock breeders are giving due importance to management of cattle health to cater to the growing nutritional needs of population. In developed countries market will be stagnant in coming years because of less consumption of cattle meat and dairy products.

Major company players are looking at the entire cattle healthcare ecosystem to maximize value for farmers. Creating value in addition to the products and services that firms offer has been a key strategy. The E=P+S program, for instance, helps farmers become profitable while keeping their operations sustainable given more discriminating preferences of end-consumers.

In this report, the market is segmented by type of disease into vaccines, Paraciticides, Anti-Infectives; Medicinal feed additives, and other pharmaceuticals. The market is further segmented by diagnostics -Enzyme Linked Sorbent Assay (ELISA), Rapid Immuno migration (RIM), and Agar Gel Immuno diffusion (AGID), and genetics. Regional markets analyzed in this report are North America, Europe, Asia-Pacific and the rest of the world (Row).

What the report offers

  • 1) Market definition for Global cattle healthcare with information on drivers and restraints.
  • 2) Market Analysis involving Cattle healthcare products available in market, relation between animal medicines and human medicines.
  • 3) Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
  • 4) Extensively researched competitive landscape with profiles of major companies along with their market share.
  • 5) A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Reasons for buying this report

  • 1) We provide you the longest market segmentation by type of products (vaccines, paraciticides, anti-infectives, medicinal feed additives and other pharmaceuticals), By Diagnostic market, by Genetics market and by Geography.
  • 2) Would be of assistance in providing a comprehensive analysis of the major trends, innovations and associated prospects for market growth over the coming half a decade.
  • 3) Wide-ranging information provided about the leading market players, major strategies adopted by them and new products launched by them.

Management of livestock to cater to the growing nutritional needs of populations. But with various kinds of diseases reducing global animal production, animal healthcare is gaining significant importance. Emerging economies thus offer significant potential for animal health industry in the near future.

The mature markets of North America and Western Europe, however, are supporting the growth of animal health market as these regions are characterized by strong growth, particularly in the companion animals sector.

Table of Contents

1.INTRODUCTION

  • 1.1. Market Definition
  • 1.2. Market Recent Trends

2. Market Analysis

  • 2.1. Market Animal Health Products
  • 2.2. Animal medicines vs human Medicines

3. Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Increase in pet ownership
    • 3.1.2. Improved Nutrition
    • 3.1.3. Intensifying consumer focus on food safety
    • 3.1.4. Greater Livestock production
    • 3.1.5. Increasing Zoonotic and Foodborne Diseases
  • 3.2. Market Constraints
    • 3.2.1. Scarcity of arable land and water
    • 3.2.2. Increased competition for cultivated land
    • 3.2.3. Cost effective production
  • 3.3. Porter's Five Force Analysis
    • 3.3.1. Threat of New Entrant
    • 3.3.2. Internal Rivalry
    • 3.3.3. Buyer bargaining power
    • 3.3.4. Supplier bargaining power
    • 3.3.5. Threat of substitutes

4. Global Farm Animal Market Segmentation -By products

  • 4.1. Farm Animals
    • 4.1.1. Vaccines
    • 4.1.2. Paraciticides
    • 4.1.3. Anti-Infectives
    • 4.1.4. Medicinal Feed additives
    • 4.1.5. Other Pharmaceuticals
  • 4.2. Farm animal
    • 4.2.1Cattle
    • 4.2.2. Swine
    • 4.2.3. Poultry
    • 4.2.4. Fish
    • 4.2.5. Sheep

5. Global Farm Animal Diagnostics Market

    • 5.1.1. Enzyme Linked Immuno Sorbent Assay( ELISA)
    • 5.1.2. Rapid Immuno Migration( RIM)
    • 5.1.3. Agar gel Immuno Diffusion( AGID)

6. Global Farm Animal Genetics Market

  • 6.1. HD 50K for Angus
  • 6.2. CLARIFIDE ¨ for Dairy
  • 6.3. Sheep 50K
  • 6.4. CLARIFIDE ¨ for Nelore
  • 6.5. Others

7.Global Farm Animal Market Segmentation, By Geography

  • 7.1. North America
    • 7.1.1. US
    • 7.1.2. Mexico
    • 7.1.3Canada
  • 7.2. Europe
    • 7.2.1. France
    • 7.2.2. Italy
    • 7.2.3. Germany
    • 7.2.4. Spain
    • 7.2.5. Italy
  • 7.3. Asia-Pacific
    • 7.3.1India
    • 7.3.2. China
    • 7.3.3. Japan

8. Competitive landscape

  • 8.1. Major players in the market
  • 8.2. Mergers and acquisitions
  • 8.3. New product launches
  • 8.4. Agreement, Collaborations and Partnerships
  • 8.5. Recommendations for New market players
  • 8.6. Recommendations for Existing market players
  • 8.7. Market Share Analysis

9.Company profiles

  • 9.1. Zoetis animal healthcare
    • 9.1.1. Financial Overview
    • 9.1.2. Business overview
    • 9.1.3. Business strategies
  • 9.2. Merck
    • 9.2.1Financial Overview
    • 9.2.2. Business overview
    • 9.2.3. Business strategies
  • 9.3. Merial (Animal Health Division Of Sanofi)
    • 9.3.1. Financial Overview
    • 9.3.2. Business overview
    • 9.3.3. Business strategies
  • 9.4. Elanco
    • 9.4.1. Financial Overview
    • 9.4.2. Business overview
    • 9.4.3. Business strategies
  • 9.5. Bayer healthcare
    • 9.5.1. Financial Overview
    • 9.5.2. Business overview
    • 9.5.3. Business strategies
  • 9.6. Novartis Animal Health, Inc.
    • 9.6.1. Financial Overview
    • 9.6.2. Business overview
    • 9.6.3. Business strategies
  • 9.7. Virbac
    • 9.7.1. Financial Overview
    • 9.7.2. Business overview
    • 9.7.3. Business strategies
  • 9.8. Boehringer Ingelheim
    • 9.8.1. Financial Overview
    • 9.8.2. Business overview
    • 9.8.3. Business strategies

10. Appendix

  • 10.1. Abbreviations
  • 10.2. Sources
  • 10.3. Bibliography
  • 10.4. Disclaimer
Back to Top